186 related articles for article (PubMed ID: 18852267)
1. Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II.
Ryan TM; Howlett GJ; Bailey MF
J Biol Chem; 2008 Dec; 283(50):35118-28. PubMed ID: 18852267
[TBL] [Abstract][Full Text] [Related]
2. Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils.
Ryan TM; Teoh CL; Griffin MD; Bailey MF; Schuck P; Howlett GJ
J Mol Biol; 2010 Jun; 399(5):731-40. PubMed ID: 20433849
[TBL] [Abstract][Full Text] [Related]
3. Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation.
Teoh CL; Bekard IB; Asimakis P; Griffin MD; Ryan TM; Dunstan DE; Howlett GJ
Biochemistry; 2011 May; 50(19):4046-57. PubMed ID: 21476595
[TBL] [Abstract][Full Text] [Related]
4. NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.
Ryan TM; Griffin MD; Bailey MF; Schuck P; Howlett GJ
Biochemistry; 2011 Nov; 50(44):9579-86. PubMed ID: 21985034
[TBL] [Abstract][Full Text] [Related]
5. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
[TBL] [Abstract][Full Text] [Related]
7. Visualization of polymorphism in apolipoprotein C-II amyloid fibrils.
Teoh CL; Yagi H; Griffin MD; Goto Y; Howlett GJ
J Biochem; 2011 Jan; 149(1):67-74. PubMed ID: 20889492
[TBL] [Abstract][Full Text] [Related]
8. The Role of Lipid in Misfolding and Amyloid Fibril Formation by Apolipoprotein C-II.
Ryan TM; Mok YF; Howlett GJ; Griffin MD
Adv Exp Med Biol; 2015; 855():157-74. PubMed ID: 26149930
[TBL] [Abstract][Full Text] [Related]
9. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
Hung A; Griffin MD; Howlett GJ; Yarovsky I
J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
[TBL] [Abstract][Full Text] [Related]
10. An equilibrium model for linear and closed-loop amyloid fibril formation.
Yang S; Griffin MD; Binger KJ; Schuck P; Howlett GJ
J Mol Biol; 2012 Aug; 421(2-3):364-77. PubMed ID: 22370559
[TBL] [Abstract][Full Text] [Related]
11. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrils.
Zlatic CO; Mao Y; Todorova N; Mok YF; Howlett GJ; Yarovsky I; Gooley PR; Griffin MDW
FEBS J; 2018 Aug; 285(15):2799-2812. PubMed ID: 29791776
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II.
Mao Y; Zlatic CO; Griffin MD; Howlett GJ; Todorova N; Yarovsky I; Gooley PR
Biochemistry; 2015 Aug; 54(31):4805-14. PubMed ID: 26196342
[TBL] [Abstract][Full Text] [Related]
14. Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils.
Mao Y; Teoh CL; Yang S; Zlatic CO; Rosenes ZK; Gooley PR; Howlett GJ; Griffin MD
Biochemistry; 2015 Feb; 54(6):1421-8. PubMed ID: 25609257
[TBL] [Abstract][Full Text] [Related]
15. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
[TBL] [Abstract][Full Text] [Related]
16. Lipid-apolipoprotein interactions in amyloid fibril formation and relevance to atherosclerosis.
Howlett GJ; Ryan TM; Griffin MDW
Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):502-507. PubMed ID: 35818279
[TBL] [Abstract][Full Text] [Related]
17. Sub-micellar phospholipid accelerates amyloid formation by apolipoprotein C-II.
Hatters DM; Lawrence LJ; Howlett GJ
FEBS Lett; 2001 Apr; 494(3):220-4. PubMed ID: 11311244
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.
Ryan TM; Griffin MD; McGillivray DJ; Knott RB; Wood K; Masters CL; Kirby N; Curtain CC
Biophys J; 2016 Jan; 110(1):85-94. PubMed ID: 26745412
[TBL] [Abstract][Full Text] [Related]
19. The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II.
Hatters DM; Lindner RA; Carver JA; Howlett GJ
J Biol Chem; 2001 Sep; 276(36):33755-61. PubMed ID: 11447233
[TBL] [Abstract][Full Text] [Related]
20. Intra- and Intersubunit Ion-Pair Interactions Determine the Ability of Apolipoprotein C-II Mutants To Form Hybrid Amyloid Fibrils.
Todorova N; Zlatic CO; Mao Y; Yarovsky I; Howlett GJ; Gooley PR; Griffin MD
Biochemistry; 2017 Mar; 56(12):1757-1767. PubMed ID: 28229588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
